Back to Journals » Lung Cancer: Targets and Therapy » Volume 1 » Default

Standing the test of time in Europe? Gefitinib in the treatment of non-small-cell lung cancer

Total article views   Abstract views HTML views PDF downloads Totals
4,575 Dovepress* 4,575 0+ 2,130 4,575
Totals 4,575 0 2,130 4,575
*Since 13 May 2010
+Since July 2016

View citations on Google Scholar